ADRB2 and open-angle glaucoma: agAAbs against β2-AR (β2-agAAbs) have been detected in the sera of patients with primary open-angle glaucoma (POAG) and SOAG, as well as ocular hypertension (OHT) (Junemann et al., 2018; Hohberger et al., 2019a).